Frequency of Rare Allelic Variation in Candidate Genes among Individuals with Low and High Urinary Calcium Excretion

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Toka, Hakan R ^a,b   Genovese, Giulio ^b   Mount, David B ^a   Pollak, Martin R ^b   Curhan, Gary C ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA;

ADULT; AGED; ARTICLE; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CALCIUM; CHI-SQUARE DISTRIBUTION; CLAUDINS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 84883188231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071885     Document Type: Article

References (66)

1. Pearle MS, Calhoun EA, Curhan GC, (2005) Urologic diseases in America project: urolithiasis. J Urol 173: 848-857.
2. Yoshida O, Okada Y, (1990) Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int 45: 104-111.
3. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC, (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823.
4. Worcester EM, Coe FL, (2010) Clinical practice. Calcium kidney stones. N Engl J Med 363: 954-963.
5. Attanasio M, (2011) The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol 26: 337-346.
6. Curhan GC, Willett WC, Rimm EB, Stampfer MJ, (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833-838.
7. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ, (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126: 497-504.
8. Curhan GC, Willett WC, Knight EL, Stampfer MJ, (2004) Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 164: 885-891.
9. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, et al. (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155: 839-843.
10. Taylor EN, Stampfer MJ, Curhan GC, (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293: 455-462.
11. Curhan GC, Willett WC, Rimm EB, Stampfer MJ, (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8: 1568-1573.
12. Moe OW, Bonny O, (2005) Genetic hypercalciuria. J Am Soc Nephrol 16: 729-745.
13. Wrong OM, Norden AG, Feest TG, (1994) Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87: 473-493.
14. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, et al. (1994) Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8: 303-307.
15. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, et al. (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285: 103-106.
16. Hoenderop JG, van Leeuwen JP, van der Eerden BC, Kersten FF, van der Kemp AW, et al. (2003) Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112: 1906-1914.
17. Maher B, (2008) Personal genomes: The case of the missing heritability. Nature 456: 18-21.
18. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, et al. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39: 513-516.
19. Fahmi S, Yang C, Esmail S, Hobbs HH, Cohen JC, (2008) Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes. Hum Mol Genet 17: 2101-2107.
20. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
21. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, et al. (2008) Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40: 592-599.
22. Curhan GC, Taylor EN, (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73: 489-496.
23. Li H, Durbin R, (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26: 589-595.
24. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073.
25. Consortium GP, (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
26. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
27. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, et al. (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926-930.
28. Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, et al. (2012) Claudin-14 regulates renal Ca(+)(+) transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 31: 1999-2012.
29. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, et al. (2006) Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79: 949-957.
30. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, et al. (2009) Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 106: 15350-15355.
31. Toka HR, Al-Romaih K, Koshy JM, Dibartolo S, Kos CH, et al. (2012) Renal tubule-specific calcium-sensing receptor deficient mice display PTH-independent hypocalciuria. J Am Soc Nephrol.
32. Melnick JZ, Preisig PA, Moe OW, Srere P, Alpern RJ, (1998) Renal cortical mitochondrial aconitase is regulated in hypo- and hypercitraturia. Kidney Int 54: 160-165.
33. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, et al. (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115-1122.
34. Tosukhowong P, Tungsanga K, Phongudom S, Sriboonlue P, (2005) Effects of potassium-magnesium citrate supplementation on cytosolic ATP citrate lyase and mitochondrial aconitase activity in leukocytes: a window on renal citrate metabolism. Int J Urol 12: 140-144.
35. Hou J, Rajagopal M, Yu AS, (2013) Claudins and the kidney. Annu Rev Physiol 75: 479-501.
36. Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, et al. (2012) Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephrocalcinosis. Proc Natl Acad Sci U S A 109: 14241-14246.
37. Dimke H, Desai P, Borovac J, Lau A, Pan W, et al. (2013) Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion. Am J Physiol Renal Physiol 304: F761-769.
38. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, et al. (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449.
39. Uchida S, (2000) Physiological role of CLC-K1 chloride channel in the kidney. Nephrol Dial Transplant 15 Suppl 6: 14-15.
40. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, et al. (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17: 171-178.
41. Rendina D, Mossetti G, De Filippo G, Cioffi M, Strazzullo P, (2006) Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak. J Clin Endocrinol Metab 91: 959-963.
42. Thomee C, Schubert SW, Parma J, Le PQ, Hashemolhosseini S, et al. (2005) GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone. J Clin Endocrinol Metab 90: 2487-2492.
43. Yoshida T, Fujimori T, Nabeshima Y, (2002) Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143: 683-689.
44. Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, et al. (2008) NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359: 1128-1135.
45. Palmada M, Poppendieck S, Embark HM, van de Graaf SF, Boehmer C, et al. (2005) Requirement of PDZ domains for the stimulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase SGK1. Cell Physiol Biochem 15: 175-182.
46. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, et al. (1996) Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183-188.
47. Seidler U, Singh A, Chen M, Cinar A, Bachmann O, et al. (2009) Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension. Exp Physiol 94: 175-179.
48. Parkinson DB, Thakker RV, (1992) A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1: 149-152.
49. Ba J, Brown D, Friedman PA, (2003) Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 285: F1233-1243.
50. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, et al. (1996) Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14: 152-156.
51. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, et al. (1996) Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24-30.
52. Okamoto N, Aruga S, Matsuzaki S, Takahashi S, Matsushita K, et al. (2007) Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol 14: 344-349.
53. Bergeron MJ, Clemencon B, Hediger MA, Markovich D, (2013) SLC13 family of Na(+)-coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med 34: 299-312.
54. Nota B, Struys EA, Pop A, Jansen EE, Fernandez Ojeda MR, et al. (2013) Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet 92: 627-631.
55. Dawson PA, Russell CS, Lee S, McLeay SC, van Dongen JM, et al. (2010) Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice. J Clin Invest 120: 706-712.
56. Heneghan JF, Akhavein A, Salas MJ, Shmukler BE, Karniski LP, et al. (2010) Regulated transport of sulfate and oxalate by SLC26A2/DTDST. Am J Physiol Cell Physiol 298: C1363-1375.
57. Wang Z, Wang T, Petrovic S, Tuo B, Riederer B, et al. (2005) Renal and intestinal transport defects in Slc26a6-null mice. Am J Physiol Cell Physiol 288: C957-965.
58. Chau H, El-Maadawy S, McKee MD, Tenenhouse HS, (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18: 644-657.
59. Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, et al. (2006) Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab 91: 4022-4027.
60. Zhang Z, Liu KX, He JW, Fu WZ, Yue H, et al. (2012) Identification of two novel mutations in the SLC4A1 gene in two unrelated Chinese families with distal renal tubular acidosis. Arch Med Res 43: 298-304.
61. Alper SL, Darman RB, Chernova MN, Dahl NK, (2002) The AE gene family of Cl/HCO3- exchangers. J Nephrol 15 Suppl 5: S41-53.
62. Loh NY, Bentley L, Dimke H, Verkaart S, Tammaro P, et al. (2013) Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5. PLoS One 8: e55412.
63. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, et al. (2008) Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 17: 1613-1618.
64. Gudbjartsson DF, Holm H, Indridason OS, Thorleifsson G, Edvardsson V, et al. (2010) Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 6: e1001039.
65. Ruggiero M, Pacini S, Amato M, Aterini S, Chiarugi V, (1999) Association between vitamin D receptor gene polymorphism and nephrolithiasis. Miner Electrolyte Metab 25: 185-190.
66. Mayan H, Munter G, Shaharabany M, Mouallem M, Pauzner R, et al. (2004) Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation. J Clin Endocrinol Metab 89: 4025-4030.